According to the latest market research study published by P&S Intelligence, the pharmacogenomics market is expected to grow at a compound annual growth rate (CAGR) of 7.4%, reaching USD 10,505.3 million by 2030. This growth is driven by the rising prevalence of infectious diseases and various cancer types, alongside the increasing adoption of personalized medicine.
In recent years, the genotyping segment has held the largest market share due to healthcare professionals' recommendations for obta